IMA - Ikena Oncology, Inc.
5.81
-0.190 -3.270%
Share volume: 30,083
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.00
-0.19
-0.03%
Summary score
37%
Profitability
43%
Dept financing
21%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.41%
Return on assets
-9.06%
Return on sales
-1446.85%
Return on invested capital
737.24%
Total debt ratio
12.06%
Debt ratio change over timeo
-1.04%
Current Ratio
11.89%
Quick Ratio
9.57%
Cash Position Ratio
7.74%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.02%
Return on sales
-289.13%
Return on invested capital
0%
Total debt ratio
10.95%
Debt ratio change over timeo
0%
Current Ratio
13.14%
Quick Ratio
0%
Cash Position Ratio
7.45%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.83%
Return on sales
-289.13%
Return on invested capital
0%
Total debt ratio
12.97%
Debt ratio change over time
0%
Current Ratio
12.49%
Quick Ratio
0%
Cash Position Ratio
8.41%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.55%
Return on assets
-99.16%
Return on sales
-520.18%
Return on invested capital
27.77%
Total debt ratio
-103.89%
Debt ratio change over time
-1.04%
Current Ratio
-2.98%
Quick Ratio
-3.3%
Cash Position Ratio
-3.01%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -10.41% | 0% | 5.97% | 8.91% |
| Return on assets | -9.06% | 2.97% | 3.34% | 2.04% |
| Return on sales | -1446.85% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 737.24% | 0% | 3.51% | 10.25% |
| Profitability | 25% | 47% | 67% | 60% |
| Total debt ratio | 12.06% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.04% | 14.34% | 187.33% | 9.75% |
| Dept financing | 3% | 27% | 43% | 13% |
| Current Ratio | 13.14% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 7.45% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 9% | 8% | 11% |
| Short-term ratios | IMA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -8.02% | 3.27% | 4.7% | 1.36% |
| Return on sales | -289.13% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 10.95% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 10% |
| Current Ratio | 13.14% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 7.45% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 17% | 23% | 32% |